Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer’s disease: a randomized, controlled clinical trial

GPS driving: a digital biomarker for preclinical Alzheimer disease

Data on data on 247,149 people has found people with mild cognitive impairment (MCI) who engage in as little as 10 minutes of moderate to vigorous exercise a few times a week may be helping to slow the progression to Alzheimer’s or similar dementia

A new vaccine effectively reduced beta-amyloid (Aβ) and tau pathology in bigenic mice, by generating high Aβ- and tau-specific antibodies that led to significant reductions of both pathologies in the brain, supporting further development of this vaccine for testing in human Alzheimer’s disease.

The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease